Testing ultrasound and near-infrared light to predict brain bleeding
Part of Brain & nervous system clinical trials.
This study looks at using two noninvasive tools on very preterm newborns to better predict whether an intraventricular hemorrhage (bleeding in the brain’s fluid spaces) may happen. If successful, it could help doctors spot risk earlier and monitor or treat babies sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a preterm baby born at or before 27 weeks and 6 days of pregnancy
- The baby must not have known genetic or birth (congenital) conditions that could affect heart or brain oxygen readings
- There should be no known genetic or congenital problem expected to change how oxygen is measured
- There must not be a comfort-only (palliative) care plan before or right after birth
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses advanced MRI scans to look at the brains of newborns who have had bleeding in the brain (IVH) and developed a condition called PHVD (fluid buildup after bleeding). The goal is to learn more about the brain and how it is affected, which could help improve care for these babies.
This trial tests a light therapy device in newborns who had a severe form of brain bleeding (intraventricular hemorrhage grade 3 or 4) within the first month of life. The goal is to see if this non-invasive treatment may help improve recovery.
This study looks at the outcomes of brain bleeding (intraventricular hemorrhage) in very premature babies. It aims to understand how these babies do and what helps them, which may lead to better care.
This trial tests a treatment called neuroendoscopic lavage—a way to wash out a severe brain bleed in newborns using a tiny camera. It may help prevent fluid buildup and brain damage. Doctors want to see if it works better than regular care for babies under one month old with this condition.
This study uses a safe, painless ultrasound to measure blood flow in the brains of newborns (both full-term and preterm) in the first 48 hours after birth. The goal is to understand how blood flow differs in these babies, which may help improve care.
This study tests a special, non-invasive sensor (near-infrared light) to help doctors choose the best cooling treatment for some newborns after brain injury. It may improve how well cooling works and how safely it’s managed in the first week of life.
Hear when a new Intraventricular Hemorrhage of Newborn Grade 2 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.